Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ittel, T. H.
Right arrow Articles by Sieberth, H. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ittel, T. H.
Right arrow Articles by Sieberth, H. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (1989) 4: 957-965
© 1989 European Renal Association-European Dialysis and Transplant Association

research-article

Reduced Deposition of Aluminium in Trabecular Bone of Uraemic Rats Treated with Dihydroxylated Vitamin D Metabolites

T. H. Ittel1,, F. Hofstädter2, U. Gladziwa1 and H. G. Sieberth1

1Departments of Internal Medicine II RWTH, Aachen, FRG 2Departments of Pathology RWTH, Aachen, FRG

Correspondence and offprint requests to: Correspondence and offprint requests to: Dr T. H. Ittel, Med Klinik II, RWTH, Aachen, 5100, Pauwelsstrasse, FRG

The rate of aluminium accumulation in bone may be related to the presence of vitamin D metabolites. The present study investigated the effect of 1,25(OH)2D3 (24 pmol/d s.c.) and 24R,25(OH)2D3 (480 pmol/day), combined or alone, on the deposition of aluminium (119 µmol/kg per day) in bone of uraemic rats during concomitant parenteral administration of aluminium for 9 weeks. Bone histomorphometry of trabecular bone revealed a severe low-turnover osteodystrophy in aluminium-treated uraemic rats, as evidenced by a decrease in osteoblastic osteoid surfaces and mineral apposition rates. 1,25(OH)2D3 as well as 24R,25(OH)2D3 decreased stainable bone aluminium and the aluminium content of trabecular bone and, in parallel, the number of osteoblasts and osteoclasts increased. Additional treatment with one or both vitamin D metabolites 14 days prior to the aluminium load further improved these results. Despite these effects, dynamic histomorphometric parameters remained suppressed and osteoidosis persisted. Serum PTH concentrations were significantly elevated in aluminium-loaded uraemic rats treated with 24R,25(OH)2D3 alone compared to controls. In conclusion, administration of 1,25(OH)2D3 or 24R,25(OH)2D3 reduces the accumulation of aluminium in trabecular bone in uraemic rats and prevents some of its excess toxicity. The mechanism of action may be different for either vitamin D metabolite; however, combined treatment does not result in further reduction of the accumulation rate of aluminium in bone in this model.

Keywords: Aluminium; Renal osteodystrophy; Vitamin D; 1,25(OH)2D3 24R,25(OH)2D3


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.